Widespread cutaneous involvement by invasive Apophysomyces elegans in a gravid patient following trauma

Cutis

Volumn 72, Issue 3, 2003, Pages 221-224+227

  Carter, J Elliot ^a,b   Ulusarac, Ozlem ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; AZTREONAM; CEFAZOLIN; CLINDAMYCIN; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; VANCOMYCIN;

ADULT; AMPUTATION; ANTIBIOTIC THERAPY; ANTIFUNGAL ACTIVITY; APOPHYSOMYCES ELEGANS; ARTICLE; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CULTURE MEDIUM; DEBRIDEMENT; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ECCHYMOSIS; ELBOW; FEMALE; FOREARM; HEAD INJURY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFECTION PREVENTION; INSTITUTIONAL CARE; MYCOSIS; PREGNANCY; SKIN BIOPSY; SKIN INFECTION; SKIN ULCER; SURGICAL TECHNIQUE; TRAFFIC ACCIDENT; TREATMENT OUTCOME; ZYGOMYCETES;

ACCIDENTS, TRAFFIC; ADULT; ANTIFUNGAL AGENTS; CRANIOCEREBRAL TRAUMA; DEBRIDEMENT; ECCHYMOSIS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; WOUND INFECTION; ZYGOMYCOSIS;

EID: 0141924583     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chandler FW, Watts JC. Zygomycosis. In: Connor DH, Chandler FW, Schwartz DA, et al, eds. Pathology of Infectious Disease. Vol 2. Stanford, Conn: Appleton & Lange; 1997:1113-1119.
2. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236-301.
3. Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 2001;125:375-378.
4. Roberts G. Labortory methods in basic mycology. In: Baron EJ, Finegold SM, eds. Bailey & Scott's Diagnostic Microbiology. 8th ed. St. Louis, Mo: CV Mosby Co; 1990:745-746.
5. Fisher J, Tuazon CU, Geelhoed GW. Mucormycosis in transplant patients. Am Surg. 1980;46:315-322.
6. Ryan-Poirier K, Eiseman RM, Beaty JH. Post-traumatic cutaneous mucormycosis in diabetes mellitus: short-term antifungal therapy. Clin Pediatr. 1988;27:609-612.
7. Mousa HA, Al-Bader SM, Hassan DA. Correlation between fungus isolated from burn wounds and burn care units. Burns. 1999;25:145-147.
8. Koneman EW, Allen SD, Janda WM, et al. Mycology. In: Color Atlas and Textbook of Diagnostic Microbiology. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1997:999-1001.
9. Richardson MD, Koukila-Kähkölä P, Shankland GS. Rhizopus, Rhizomucor, Absidia, and other agents of systemic and subcutaneous zygomycoses. In: Murray PR, Baron EJ, Jorgenson JH, et al, eds. Manual of Clinical Microbiology. Vol 2. 8th ed. Washington, DC: ASM Press; 2003:1761.
10. Edwards JE, Pappas PG. Fungi and fungal diseases. In: Root RK, Waldvogel F, Corey L, et al, eds. Clinical Infectious Disease: A Practical Approach. New York, NY: Oxford University Press; 1999:46-47.
11. Gruhn JG, Sanson J. Mycotic infections in leukemic patients at autopsy. Cancer. 1963;16:61-72.
12. Brown AE. Overview of fungal infections in cancer patients. Semin Oncol. 1990;17:2-5.
13. Vainrub B, Macareno A, Mandel S, et al. Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med. 1988;84:546-548.
14. Adam RG, Hunter G, DiTomasso J, et al. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis. 1994;19:67-76.
15. Jain JK, Markowitz A, Khilanani PV. Case report: localized mucormycosis following intramuscular corticosteroid, case report and review of the literature. Am J Med Sci. 1978;275:209-216.
16. Oberle AD, Penn RL. Nosocomial invasive Saksenae vasiformis infection. Am J Clin Pathol. 1983;80:885-888.
17. Hicks WL, Nowels K, Troxel J. Primary cutaneous mucormycosis. Am J Otolaryngol. 1995;16:265-268.
18. Mead JH, Lupton GP, Dillavou CL, et al. Cutaneous Rhizopus infection: occurrence as a postoperative complication associated with an elasticized adhesive dressing. JAMA. 1979;242:272-274.
19. Newton WD, Cramer FS, Norwood SH. Necrotizing fasciitis from invasive phycomycetes. Crit Care Med. 1987;15:331-332.
20. Misra PC, Srivastava KJ, Lata K. Apophysomyces, a new genus of the Mucorales. Mycotaxon. 1979;8:377-382.
21. Ellis JJ, Ajello L. An unusual source for Apophysomyces elegans and a method for sporulation of Saksenaea vasiformis. Mycologia. 1982;77:144-145.
22. Meis JF, Kullberg BJ, Pruszczynski M, et al. Severe osteomyelitis due to the zygomycete Apophysomyces elegans. J Clin Microbiol. 1994;32:3078-3081.
23. Lawrence RM, Snodgrass WT, Reichel GW, et al. Systemic zygomycosis caused by Apophysomyces elegans. J Med Vet Mycol. 1986;24:57-65.
24. Okhuysen PC, Rex JH, Kapusta M. Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin Infect Dis. 1994;19:329-331.
25. Lombardi G, Padhye AA, Standard PG, et al. Exoantigen tests for the rapid and specific identification of Apophysomyces elegans and Saksenaea vasiformis. J Med Vet Mycol. 1989;27:113-120.
26. Caceres AM, Sardina C, Marcano R, et al. Apophysomyces elegans limb infection with a favorable outcome: case report and review. Clin Infect Dis. 1997;25:331-332.